Company Filing History:
Years Active: 1997-2000
Title: Elizabeth DiBlasio-Smith: Innovator in Fusion Proteins
Introduction
Elizabeth DiBlasio-Smith is an accomplished inventor currently based in Tyngsboro, Massachusetts. With a remarkable contribution to the field of biotechnology, she has been granted two patents that underscore her expertise in the development of fusion proteins.
Latest Patents
Her latest patents focus on innovative peptide and protein fusions to thioredoxin and thioredoxin-like molecules. One notable patent details a fusion molecule that consists of a DNA sequence encoding a thioredoxin-like protein fused to another sequence encoding a second peptide or protein. This fusion can occur at various sites, enhancing the molecule's functionality. These fusion proteins are engineered to be expressed in suitable host cells, resulting in high yields of stable and soluble proteins. Moreover, the technology allows for selective release from bacterial cytoplasm, enhancing the efficiency of genetic material utilization in practical applications.
Career Highlights
Elizabeth is currently affiliated with Genetics Institute, Inc., where she harnesses her innovative capabilities to advance biotechnological research and applications. Her commitment to pushing the boundaries of science has placed her at the forefront of her field.
Collaborations
Throughout her career, Elizabeth has collaborated with esteemed colleagues such as John R. McCoy and Kathleen Grant. These collaborations highlight her ability to work cohesively within a team environment to achieve significant advancements in biotechnology.
Conclusion
Elizabeth DiBlasio-Smith stands out as a significant contributor to the world of innovations in biopharmaceuticals. Her patents serve as a testament to her creativity and scientific rigor, setting the stage for future developments that could benefit multiple industries. Her work continues to inspire new approaches to protein engineering and therapeutic solutions.